Reply to: Comments on: Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein

Rouslan Kotchetkov, David Susman, Divaya Bhutani, Kaspar Broch, Angela Dispenzieri, Francis K. Buadi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)743-744
Number of pages2
JournalInternational Journal of Cancer
Issue number3
StatePublished - Aug 1 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this